Proteomic Analysis for Biomarkers in Early Detection of Cancer在癌症的早期检测的生物标志物的蛋白质组学分析.pptVIP

Proteomic Analysis for Biomarkers in Early Detection of Cancer在癌症的早期检测的生物标志物的蛋白质组学分析.ppt

  1. 1、本文档共19页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Proteomic Analysis for Biomarkers in Early Detection of Cancer在癌症的早期检测的生物标志物的蛋白质组学分析.ppt

Proteomic Analysis for Biomarkers in Early Detection of Cancer Sherry Funston Emily Faerber Brandon Lesniak Protein Biomarkers Proteins used as an indicator of a specific state (such as a disease) Changes in protein expression or state can be “biomarkers” for risk or progression of a disease Why use plasma? Easily obtained Widely used clinically Contains many proteins (a good representation of the body’s proteome) Plasma has already been used in the diagnosis of many other diseases Plasma vs Serum Plasma: Add anti-coagulant (EDTA) Centrifuge Remove plasma, leave cells behind Serum: Allow blood to clot Remove supernatant = serum Variable results Biomarkers potentially useful in cancer diagnosis Why use proteomic analysis? Proteomics The “protein complement of a given genome” (Dr. Marc Wilkins) Basically, all proteins that are being expressed by a cell, tissue, or genome Proteomic analysis reveals which proteins are being expressed with accuracy, speed, and resolution Has the potential to diagnose diseases, disease states, and effect of treatment of those diseases Approaches to Biomarker Discovery Target Specific Antibodies Requires previous knowledge of proteins Low-throughput Global/Nondirected Profiling of unidentified proteins Generate profiles of identified proteins High-throughput MALDI-TOF-MS/MS SELDI-TOF-MS Sample depletion/enrichment Sample depletion/enrichment Sample depletion/enrichment Sample fractionation/separation Research Research has focused on ovarian, prostate, and breast cancer SELDI-TOF-MS has identified biomarker profiles with 100% sensitivity and 95% specificity Studies have successfully: Identified patients with tumors Identified type of tumor Distinguished between benign and malignant Identified possible treatments Distinguished response/no response to treatment Problems to Overcome Finding biomarkers that are: Tumor specific Tissue specific Sample complexity Correlation to population in vivo vs. in vitro behavior Clinical Applicat

您可能关注的文档

文档评论(0)

cai + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档